MALAT1 and cancer: The silencing of MALAT1 by siRNA or ASO has been reported to exhibit positive regulations in in vivo models of tumorigenesis by improving features such as tumor cell proliferation, migration, invasion, and apoptosis in various cancer types including lung cancer [261, 262], pancreatic cancer [262] and multiple myeloma [259].